Published on January 9, 2010 at 5:55 AM
HealthSTAR's LehmanMillet, the leading agency
devoted to working with health care companies changing standards of care,
today announced the addition of two new accounts: Myriad Genetics and
Breathe Technologies.
"We are excited to partner with these courageous innovators," said Bruce
Lehman, President and CEO, LehmanMillet. "The work they are doing
represents important advances in diagnosis and treatment of conditions and
diseases in which there are significant unmet medical needs. Bringing these
standard-changers to patients and their doctors demands standard-changing
education and communications."
Myriad Genetics, an early pioneer and current global leader in molecular
diagnostics and genetic testing, has retained LehmanMillet to help raise
awareness of BRACAnalysis®, the emerging standard of care for detecting
hereditary breast and ovarian cancer risk. LehmanMillet recently launched
JUST ASK™!, a public awareness campaign aimed at educating women and
their doctors about the importance of knowing who is at risk and who should
have BRACAnalysis®, a blood test that identifies the BRCA mutations
responsible for most cases of hereditary breast and ovarian cancer. With a
targeted combination of television, print, internet and social media, JUST
ASK! encourages women to talk to their doctor if they have a family history
of breast and/or ovarian cancer and to be aware of steps that can reduce
their risk.
Breathe Technologies Inc. is developing a unique family of compact,
ultra-lightweight, ambulatory respirator ventilator systems. Its device
uses proprietary technology to leave a much smaller, lighter footprint than
current ventilators, and it also requires less gas than larger units. The
company believes its innovative technology will fill an unmet need for
patients with severe ventilator insufficiency, both in the hospital setting
and in the home.
SOURCE: HealthSTAR Communications